1.Qingjie Huagong Formula (清解化攻方) Combined with Conventional Western Medicine in the Treatment of Acute Pancreatitis:A Randomized,Double-Blind,Placebo-Controlled Trial
Xialan LAI ; Guozhong CHEN ; Xiaodong ZHU ; Weizhizi LI ; Xiping TANG ; Xiaoyi HUANG ; Dewen LI
Journal of Traditional Chinese Medicine 2026;67(19):2095-2102
ObjectiveTo investigate the clinical efficacy of oral/ gastric tube/ jejunal tube administration or retention enema of Qingjie Huagong Formula (清解化攻方, QHF) mirabilite abdominal bag external application combined with conventional western medicine in patients with acute pancreatitis (AP). MethodsA prospective, randomized, double-blind, placebo-controlled trial was conducted. A total of 128 AP patients were enrolled and randomly assigned to a control group and a treatment group, with 64 cases in each group. The control group received placebo and conventional western medicine, while the treatment group additionally received oral/ gastric tube/ jejunal tube administration or retention enema of QHF, and mirabilite abdominal bag external application. Both groups received treatment from admission to discharge as one complete course, with the maximum treatment duration not exceeding 14 days.The primary outcome was the severity grading of AP. Secondary outcomes were clinical efficacy, laboratory indicators including white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), blood urea nitrogen (BUN), lactate (Lac), and D-dimer, gastrointestinal function recovery indicators including time to relief of abdominal pain, time to recovery of bowel sounds, and time to resumption of enteral nutrition, total fluid volume administered within 24 h after admission, intra-abdominal pressure, length of hospital stay, hospitalization costs, and incidence of complications. ResultsDuring the treatment period, 3 cases dropped out in the control group and 9 cases in the treatment group, leaving 116 cases for final analysis (55 in the treatment group and 61 in the control group). After treatment, the markedly effective rate and overall effective rate in the treatment group were 69.09% (38/55) and 92.73% (51/55), respectively, which was higher than 49.18% (30/61) and 80.33% (49/61) in the control group. The severity of the disease in the treatment group was significantly lower than that in the control group (P<0.05). Compared to the control group, the treatment group showed significantly reduced levels of WBC, CRP, PCT, BUN, Lac, and D-dimer; the time to relief of abdominal pain, time to recovery of bowel sounds, and time to resumption of enteral nutrition were significantly shortened; the fluid volume administered within 24 h after admission and intra-abdominal pressure were significantly reduced, as well as the length of hospital stay and hospitalization costs (P<0.05 or P<0.01). The incidences of acute kidney injury, systemic inflammatory response syndrome, and infected pancreatic necrosis in the treatment group were significantly lower than those in the control group (P<0.05). ConclusionQHF combined with conventional western medicine can significantly improve the inflammatory status of AP patients, promote gastrointestinal function recovery, reduce intra-abdominal pressure and fluid resuscitation requirements, lower the risk of certain complications, and shorten the length of hospital stay.
2.Qingjie Huagong Formula (清解化攻方) Combined with Conventional Western Medicine in the Treatment of Acute Pancreatitis:A Randomized,Double-Blind,Placebo-Controlled Trial
Xialan LAI ; Guozhong CHEN ; Xiaodong ZHU ; Weizhizi LI ; Xiping TANG ; Xiaoyi HUANG ; Dewen LI
Journal of Traditional Chinese Medicine 2026;67(19):2095-2102
ObjectiveTo investigate the clinical efficacy of oral/ gastric tube/ jejunal tube administration or retention enema of Qingjie Huagong Formula (清解化攻方, QHF) mirabilite abdominal bag external application combined with conventional western medicine in patients with acute pancreatitis (AP). MethodsA prospective, randomized, double-blind, placebo-controlled trial was conducted. A total of 128 AP patients were enrolled and randomly assigned to a control group and a treatment group, with 64 cases in each group. The control group received placebo and conventional western medicine, while the treatment group additionally received oral/ gastric tube/ jejunal tube administration or retention enema of QHF, and mirabilite abdominal bag external application. Both groups received treatment from admission to discharge as one complete course, with the maximum treatment duration not exceeding 14 days.The primary outcome was the severity grading of AP. Secondary outcomes were clinical efficacy, laboratory indicators including white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), blood urea nitrogen (BUN), lactate (Lac), and D-dimer, gastrointestinal function recovery indicators including time to relief of abdominal pain, time to recovery of bowel sounds, and time to resumption of enteral nutrition, total fluid volume administered within 24 h after admission, intra-abdominal pressure, length of hospital stay, hospitalization costs, and incidence of complications. ResultsDuring the treatment period, 3 cases dropped out in the control group and 9 cases in the treatment group, leaving 116 cases for final analysis (55 in the treatment group and 61 in the control group). After treatment, the markedly effective rate and overall effective rate in the treatment group were 69.09% (38/55) and 92.73% (51/55), respectively, which was higher than 49.18% (30/61) and 80.33% (49/61) in the control group. The severity of the disease in the treatment group was significantly lower than that in the control group (P<0.05). Compared to the control group, the treatment group showed significantly reduced levels of WBC, CRP, PCT, BUN, Lac, and D-dimer; the time to relief of abdominal pain, time to recovery of bowel sounds, and time to resumption of enteral nutrition were significantly shortened; the fluid volume administered within 24 h after admission and intra-abdominal pressure were significantly reduced, as well as the length of hospital stay and hospitalization costs (P<0.05 or P<0.01). The incidences of acute kidney injury, systemic inflammatory response syndrome, and infected pancreatic necrosis in the treatment group were significantly lower than those in the control group (P<0.05). ConclusionQHF combined with conventional western medicine can significantly improve the inflammatory status of AP patients, promote gastrointestinal function recovery, reduce intra-abdominal pressure and fluid resuscitation requirements, lower the risk of certain complications, and shorten the length of hospital stay.
3.Consensus on diagnosis and treatment of adolescent idiopathic scoliosis
Yushu BAI ; Kai CHEN ; Jie SHAO ; Xiao ZHAI ; Ming CHEN ; Weishi LI ; Jianzhong XU ; Bangping QIAN ; Zezhang ZHU ; Feng ZHU ; Chunde LI ; Jianguo ZHANG ; Jianxiong SHEN ; Dingjun HAO ; Xiaodong ZHU ; Junlin YANG ; Xuejun ZHANG ; Xuesong ZHANG ; Fangyi ZHANG ; Qijie WANG ; Wenzhi ZHANG ; Yong HAI ; Jianhua ZHAO ; Yong QIU ; Yan WANG ; Guixing QIU ; Ming LI
Academic Journal of Naval Medical University 2025;46(3):291-300
Adolescent idiopathic scoliosis(AIS)is a complex three-dimensional deformity involving coronal,sagittal,and axial planes,with a prevalence that should not be overlooked.With advancements in technology and in-depth research,an increasing number of hospitals and physicians are exploring standardized diagnostic and treatment approaches for AIS.Comprehensive and in-depth understanding is required for AIS,including its etiology,screening and diagnosis,classification,assessment and examination,treatment options,exploration of current focus,and evaluation of quality of life.Such understanding ensures that the diagnostic and treatment are scientific,standardized,and timely.Based on the principles of evidence-based medicine,a consensus on the diagnosis and treatment of AIS is reached after multiple discussions among spinal surgery experts,aiming to provide reference and guidance for clinical practice.
4.Exploration of the application of vehicle-mounted 5G remote mobile robotic surgical system in thyroid surgery
Meng WANG ; Wen TIAN ; Qingqing HE ; Guolou LI ; Jian ZHU ; Xiaodong MA ; Wei WEI ; Qiongqiong TAN ; Jinzhi HU ; Yingying WANG ; Peng ZHOU ; Gang WANG ; Yixin LIU ; Hejun WANG ; Yu LIU ; Lihu LIU
International Journal of Surgery 2025;52(1):28-32
Objective:To investigate the feasibility and safety of implementing a domestic vehicle-mounted remote mobile robotic surgical system in thyroid surgery applications, integrated with 5G communication technology.Methods:Using the main system located on the vehicle-mounted mobile robot operating platform of the 960th Hospital of PLA Joint Logistics Support Force and the slave system of Weifang Traditional Chinese Hospital, the remote radical thyroidectomy 5G communication technology, and analyze the clinical and information transmission data of two female patients who underwent remote mobile robot thyroid cancer surgery on October 21, 2024 at Weifang Traditional Chinese Medicine Hospital.Results:The remote radical thyroidectomy was conducted by the robosurgeons utilizing a vehicle-mounted mobile robotic surgical system, and the procedure was successfully completed without necessitating intermediate open surgery. The operation durations for patient 1 and patient 2 were 135 minutes and 108 minutes, respectively, with 7 and 13 lymph nodes dissected, respectively. The average delay in surgical data transmission was recorded at 61.9 milliseconds, with no instances of signal interruption or frame loss. The procedure proceeded smoothly, without any jamming, and the audio and video transmissions were consistently clear. Follow up for 21 days after surgery showed no complications such as hoarseness, skin damage, or lymphatic fistula.Conclusion:The implementation of a vehicle-mounted remote mobile robotic surgery system for thyroid surgery has demonstrated safety and feasibility. Furthermore, the utilization of the 5G network offers rapid data transmission and minimal latency, closely approximating the therapeutic efficacy of traditional robotic thyroidectomy.
5.Analysis of Changes in Serum KLF11,lncRNA SNHG12 Levels in Patients with Intracranial Aneurysms and Their Prognostic Value
Xiaodong WANG ; Bangjian ZHU ; Jinjing WEI
Journal of Modern Laboratory Medicine 2025;40(4):116-120,126
Objective To analyze the changes in serum levels of Krüppel-like transcription factors(KLF11)and long non-coding RNA small nucleolar RNA host gene 12(lncRNA SNHG12)in patients with intracranial aneurysm(IA),and their predictive value for prognosis.Methods A retrospective analysis was performed on 132 IA patients(IA group)who underwent interventional embolization for IA rupture and bleeding from February 2019 to February 2023,and 60 healthy people who underwent outpatient physical examination during the same period were selected as the control group.Serum levels of KLF11 was detected by enzyme-linked immunosorbent assay(ELISA),the level of lncRNA SNHG12 was detected by real-time fluorescence quantitative PCR(qRT-PCR).According to the modified Rankin scale(MRS)score,IA patients were divided into a good prognosis group(n=98,MRS score 0~2)and poor prognosis group(n=34,MRS score 3~6).Pearson correlation analysis was used to analyze the correlation between serum KLF11,lncRNA SNHG12 and cerebral hemodynamic parameters.Logistic regression analysis was used to analyze the factors affecting the prognosis of IA patients.The receiver operating characteristic curve was used to analyze the prognostic value of serum KLF11 and lncRNA SNHG12 in IA patients.Results The serum KLF11(47.12±6.58ng/L)and lncRNA SNHG12(1.89±0.36)in the IA group were lower than those in the control group(113.89±19.35ng/L,3.24±0.58),and the differences were statistically significant(t=19.695,35.476,all P<0.05).The levels of serum KLF11 and lncRNA SNHG12 in IA group were positively correlated with cerebral blood flow,cerebral blood volume and mean transit time(rKLF11=0.722,0.627,0.752;rlncRNA SNHG12=0.630,0.714,0.766,all P<0.05),and negatively correlated with intracranial pressure(r=-0.658,-0.599,all P<0.05).The proportion of CT Fisher grade 3~4 in IA patients in the poor prognosis group was higher than that in the good prognosis group,and the postoperative complication rate was higher than that in the good prognosis group,the serum KLF11(35.98±6.11 ng/L)and lncRNA SNHG12(1.12±0.30)levels were lower than those in the good prognosis group(50.98±6.90ng/L,2.16±0.39),and the differences were statistically significant(t=4.630~14.151,all P<0.05).CT Fisher grade 3~4,postoperative complications were risk factors for poor prognosis of IA patients(Wald χ2=8.403,12.049,all P<0.001),serum KLF11,lncRNA SNHG12 were protective factors(Wald χ2=5.550,7.904,all P<0.001).The AUC(95%CI)for predicting the prognosis of IA patients with the combination of serum KLF11 and lncRNA SNHG12 was 0.921(0.889~0.942),which was higher than the single detection of serum KLF11 and lncRNA SNHG12 at 0.848(0.805~0.886)and 0.810(0.767~0.852),and the differences were statistically significant(Z=5.886,4.367,all P<0.001).Conclusion The levels of serum KLF11 and lncRNA SNHG12 in IA patients are decreased,which are related to cerebral hemodynamic parameters.The combined detection has a high evaluation value for the prognosis of IA patients.
6.Expert consensus on infection prevention and control of Creutzfeldt-Jakob disease in medical institutions
Tianxiang GE ; Yangyang JIA ; Chunhui LI ; Jianrong HUANG ; Xiujuan MENG ; Xiaodong GAO ; Jingping ZHANG ; Fu QIAO ; Lijuan XIONG ; Hui LIANG ; Wei LI ; Haiyan LOU ; Wenjuan WU ; Tianxin XIANG ; Jiansen CHEN ; Biao ZHU ; Kaijin XU ; Zhihui ZHOU ; Hongliu CAI ; Meihong YU ; Yan ZHANG ; Yanwan SHANGGUAN ; Haiting FENG ; Hangping YAO ; Lei GUO ; Tieer GAN ; Weihong ZHANG ; Jimin SUN ; Ye LU ; Qun LU ; Meng CAI ; Jin SHEN ; Yunsong YU ; Anhua WU ; Liu-yi LI ; Tingting QU
Chinese Journal of Infection Control 2025;24(4):437-450
Creutzfeldt-Jakob disease(CJD)is a rapidly progressive and fatal neurodegenerative disorder caused by prions,with certain infectivity and iatrogenic transmission risks.With the rapid progress and application of new dia-gnostic biomarkers and detection methods,as well as the construction and improvement of surveillance and reporting systems,the detection of CJD in patients domestically and internationally has shown an increasing trend year by year.Due to its long incubation period and heterogeneity of early symptoms,early identification and diagnosis of the disease is difficult,increasing the risk of transmission within medical institutions.Currently,there is a lack of con-sensus on the infection prevention and control of CJD.In order to timely identify and diagnose CJD as well as effec-tively block its transmission in medical institutions,this consensus summarizes 15 clinical concerns and formulates 24 specific recommendations based on the latest domestic and international research findings and clinical evidence,as well as combines with clinical practice,aiming to standardize healthcare-associated infection prevention and control measures for CJD and reduce its transmission risk in medical institutions.
7.Asiaticoside Alleviates Renal Fibrosis in Diabetic Nephropathy Rats by Regulating the Hippo-YAP/TAZ Signaling Pathway
Xiaodong ZHU ; Xiaoyu WANG ; Chuan JIANG ; Chengmei YANG ; Shumei SHI
Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(6):1472-1477
Objective To observe the effects of asiaticoside on renal fibrosis in diabetic nephropathy(DN)rats by regulating the Hippo-yes-associated protein(YAP)/transcriptional co-activator with PDZ-binding motif(TAZ)signaling pathway.Methods A DN rat model was established by feeding a high-sugar and high-fat diet combined with intraperitoneal injection of streptozotocin(STZ).The successfully modeled rats were randomly divided into model group,low-and high-dose asiaticoside groups,and high-dose asiaticoside+XMU-MP-1(Hippo-YAP/TAZ pathway activator)group,with a normal group set as control.After group intervention,blood urea nitrogen(BUN),serum creatinine(SCr),fasting blood glucose(FBG),and 24-hour urinary protein levels were measured.Hematoxylin-eosin(HE)staining was used to observe renal histopathological changes,Masson staining was used to assess renal fibrosis,and Western Blot was used to detect the protein expressions of YAP and TAZ in renal tissue.Results Compared with the normal group,the model group showed disordered renal tissue structure,enlarged and irregular cystic cavities,enlarged renal tubules with thickened basement membranes,inflammatory cell infiltration,and significant collagen deposition in the glomeruli,renal tubules,and vascular walls.The levels of FBG,BUN,SCr,24-hour urinary protein,and the protein expressions of YAP and TAZ in renal tissue were significantly increased(P<0.05).Compared with the model group,the low-and high-dose asiaticoside groups showed significant improvement in renal tissue damage and fibrosis,with reduced levels of FBG,BUN,SCr,24-hour urinary protein,and decreased protein expressions of YAP and TAZ in renal tissue(P<0.05).Compared with the high-dose asiaticoside group,the high-dose asiaticoside+XMU-MP-1 group showed a reversal in all the above indicators.Conclusion Asiaticoside may alleviate renal fibrosis and improve renal injury in DN rats by inhibiting the Hippo-YAP/TAZ pathway.
8.Clinical application of intraperitoneal chemotherapy ports in patients with gastric cancer and peritoneal metastases
Zhong ZHANG ; Sheng LU ; Yaping GUO ; Feng BIAN ; Yongkang XU ; Xiaodong MO ; Hexia LUO ; Xinyu TANG ; Min SHI ; Jun ZHANG ; Chao YAN ; Yu CHEN ; Zhenggang ZHU
Chinese Journal of Gastrointestinal Surgery 2025;28(5):521-527
Objective:To evaluate the clinical value and safety of an intraperitoneal chemotherapy port technique in patients with gastric cancer and peritoneal metastases undergoing intraperitoneal chemotherapy.Methods:This was a retrospective, descriptive case analysis. From November 2022 to October 2024, patients diagnosed with gastric cancer and peritoneal metastases at Wuxi Branch of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine with an expected survival >3 months, underwent laparoscopic exploration combined with implantation of an intraperitoneal chemotherapy port [PORT-A-CATH II system (Model 21-4055-24)] implantation. The procedure was as follows: (1) after laparoscopic exploration, a 4-cm skin incision was made at a predetermined site and a subcutaneous pocket created by dissecting to the muscle fascia and removing subcutaneous fat as needed to position the port septum 0.5-1.0 cm from the skin surface; (2) under direct laparoscopic visualization, the abdominal cavity was punctured and a guidewire inserted, followed by an 8.5 Fr sheath, through which a catheter with three trimmed side holes was placed after removal of the sheath; (3) the catheter length in the abdominal cavity was adjusted to 25–30 cm and the catheter trimmed, and connected to the port base, ensuring it extended beyond the connector's visible hole; (4) the whole port was placed within the subcutaneous pocket, and non-absorbable sutures used to create a double purse-string suture at the catheter's abdominal entry, forming an anti-reflux ring; (5) non-absorbable sutures were used to securely fix the port to the fascia through its four base holes and the exposed catheter segments on the fascia sutured and buried; (6) patency was confirmed by injecting saline and followed by intermittent skin closure provided there was no bleeding; and (7) the catheter tip was positioned in the pelvic cavity under laparoscopic guidance. Postoperatively, the patients underwent normothermic intraperitoneal and systemic treatment. The port infusion protocol involved disinfecting the skin (>10 cm diameter) around the port, confirming the puncture site, inserting a Huber needle vertically at 90° to the port base, infusing 100 mL saline to ensure patency, followed by continuous infusion of 1000 mL paclitaxel solution, and sealing with 20 mL saline before removing the needle. No saline flushing was required between chemotherapy infusions. The primary outcomes were the incidence and management of complications post-port implantation.Results:The study cohort comprised 225 patients with gastric cancer and peritoneal metastases. Using standardized port implantation and postoperative puncture procedures, the complication rate during follow-up was 14.2% (32/225), including effusion in 14 patients (6.2%), port infection in 10 (4.4%), incision dehiscence in four (1.8%), port inversion in two (0.9%), hematoma in one (0.4%), and catheter rupture in one (0.4%). Seventy-five percent (24/32) of patients with complications recovered and continued using the port after conservative treatments (e. g., aspiration of effusions, antibiotic therapy, incision management), whereas the remaining 25.0% (8/32) with complications required surgical removal of the port because the treatment was ineffective. The presence of preoperative ascites ( P=0.019) and peritoneal cancer index score>15 ( P=0.038) were significantly associated with development of complications. Conclusions:Our standardized procedure for intraperitoneal chemotherapy port implantation is safe and feasible for patients with gastric cancer and peritoneal metastases, having a low overall complication rate. Most complications can be successfully managed with conservative treatment, the device thus providing reliable support for intraperitoneal chemotherapy.
9.Experience summary of laparoscopes adhesiolysis for adhesive intestinal obstruction: a case series of 30 patients
Yanyun HONG ; Yang DONG ; Hailong JIN ; Kankai ZHU ; Xiaodong WANG ; Yang LI ; Jiren YU ; Xiaosun LIU
Chinese Journal of Postgraduates of Medicine 2025;48(9):788-791
Objective:To evaluate the safety and efficacy of laparoscopes adhesiolysis in the treatment of adhesive intestinal obstruction.Methods:A retrospective analysis was conducted on the clinical data of 30 patients with adhesive intestinal obstruction who underwent laparoscopes adhesiolysis at the First Affiliated Hospital, Zhejiang University School of Medicine between January 2021 and December 2024. The demographics, surgical parameters and postoperative complications were recorded.Results:Among the 30 patients, 16 were male and 14 were female, with age of (55.93 ± 13.83) years. A history of abdominal surgery was present in 25 patients (83.3%). Of the surgeries, 4 cases (13.3%) were performed as emergency procedures and 26 cases (86.7%) were elective. The operative time was (125.57 ± 48.25) min, and intraoperative blood loss was (26.17 ± 16.90) ml. The time to first flatus was (3.30 ± 1.95) d, the time to first oral intake was 4.00 (3.00, 5.00) d, the hospital stay was (24.23 ± 17.97) d, and the postoperative hospital stay was 11.50 (6.75, 18.75) d. The incision pain score 0 score was in 8 cases (26.7%), 1 score in 5 cases (16.7%), 2 scores in 10 cases (33.3%), 3 scores in 3 cases (10.0%), 4 scores in 3 cases (10.0%), and 5 scores in 1 case (3.3%). One case developed a postoperative wound infection. The patients were followed up for 1 year, 1 patient experienced recurrent incomplete intestinal obstruction due to widespread peritoneal metastasis from gastric cancer.Conclusions:Laparoscopes adhesiolysis is a safe and effective treatment for adhesive intestinal obstruction, offering advantages in terms of postoperative recovery and low complication rates. The continued use of minimally invasive techniques is recommended in the management of this condition.
10.Posterior minimally invasive surgery for treating paralytic scoliosis with pelvic obliquity in children following spinal cord injury
Yi CHEN ; Xiaodong QIN ; Zhong HE ; Zhen LIU ; Saihu MAO ; Benlong SHI ; Yong QIU ; Zezhang ZHU
Chinese Journal of Orthopaedics 2025;45(2):67-76
Objective:To compare the clinical efficacy of Minimally Invasive Surgery (MIS) and traditional Posterior Spinal Fusion (PSF) in treating children with paralytic scoliosis with pelvic obliquity (PSPO) following spinal cord injury.Methods:A retrospective analysis was conducted on the data of 25 patients with PSPO who underwent surgical treatment at the Drum Tower Hospital affiliated with Nanjing University Medical School from January 2017 to June 2023. The cohort included 4 males and 21 females, aged 12.3±2.8 years (range 9-14 years). Patients were divided into the MIS group (12 cases) and the PSF group (13 cases). Radiological parameters were measured preoperatively, postoperatively, and at the last follow-up. Surgical time, intraoperative blood loss, intraoperative blood transfusion volume, length of hospital stay, total hospitalization costs, and complications were recorded. The Scoliosis Research Society questionnaires-22 (SRS-22) Chinese version were used to assess patient satisfaction and efficacy.Results:There were no statistically significant differences between the MIS and PSF groups in age, gender, Risser sign, preoperative Cobb angle for scoliosis, pelvic tilt angle, or local kyphosis angle ( P>0.05). The MIS group demonstrated surgical time of 176±30 minutes, intraoperative blood loss of 300±70 ml, blood transfusion volume of 280±175 ml, and total hospitalization costs of 87'800± 13'300 yuan, all of which were lower than PSF group, with values of 280±91 minutes, 1'433±116 ml, 1'351±996 ml, and 14'8400±26'100 yuan, respectively. These differences were statistically significant ( t=3.789, P=0.001; t=29.328, P<0.001; t=3.667, P=0.001; t=7.271, P<0.001). In the MIS group, preoperative, postoperative, and last follow-up Cobb angles were 79.11°±6.74°, 35.86°±4.98°, and 36.27°±4.84° respectively; pelvic tilt angles were 24.79°±5.58°, 9.18°±3.32°, and 8.79°±2.94°; local kyphosis angles were 38.84°±4.18°, 12.96°±4.87°, and 11.43°±6.08°, respectively. Postoperative and last follow-up angles were significantly reduced compared to preoperative values, with statistically significant differences ( P<0.05). In the PSF group, preoperative, postoperative, and last follow-up Cobb angles were 82.06°±9.26°, 34.75°±5.14°, and 35.15°±5.04° respectively; pelvic tilt angles were 26.60°±6.21°, 10.12°±3.21°, and 9.91°±2.97°; local kyphosis angles were 40.92°±7.04°, 10.92°±7.26°, and 14.02°±5.58°, respectively. Differences from preoperative to postoperative measurements were statistically significant ( P<0.05). At the last follow-up, both groups showed no significant loss of scoliosis correction, and there were no statistically significant differences between the groups postoperatively or at the last follow-up ( P>0.05). In the MIS group, one case of superficial surgical site infection and one case of postoperative atelectasis occurred. In the PSF group, two cases of deep surgical site infection, one case of poor screw placement, and two cases were transferred to the ICU postoperatively due to excessive intraoperative bleeding. Preoperative SRS-22 total scores were 2.0±0.6 for PSF and 2.1±0.4 for MIS. Postoperative SRS-22 total scores (excluding satisfaction) were 3.0±0.5 for PSF and 2.9±0.3 for MIS. The within-group differences from preoperative to postoperative were statistically significant ( P<0.05), while the between-group differences from preoperative to postoperative were not statistically significant ( P>0.05). Conclusion:Compared to the PSF technique, MIS can shorten surgery time, reduce intraoperative blood loss and perioperative complications, and decrease hospitalization costs. MIS can achieve similar early clinical efficacy.

Result Analysis
Print
Save
E-mail